SHIMODAIRA Shigetaka

FacultyDepartment of Regenerative Medicine, Regenerative Medicine Center, Department of Advanced Medicine
PositionProfessor

Researcher Profile & Settings

Degree

  • Ph.D in Medicine

Research Activities

Published Papers

  • WT1 Peptide Vaccine is Unaffected by Airport Screening X-Irradiation, (Y.Higuchi), M.Kawakubo, M.Yuzawa, K.Sano, S.Shimodaira, Austin Journal of Vaccines & Immunotherapeutics3:1010-1010Sep. 2016
  • Interferon-α-inducible Dendritic Cells Matured with OK-432 Exhibit TRAIL and Fas Ligand Pathwaymediated Killer Activity, (T.Koya), R.Yanagisawa, Y. Higuchi, K.Sano, S.Shimodaira, Scientific Reports3:1-4Feb. 2017
  • Interferon-α-inducible Dendritic Cells Matured with OK-432 Exhibit TRAIL and Fas LIgand Pathway-mediated Killer Activity, Terutsugu Koya,Ryu Yanagisawa,Yumiko Higuchi,Kenji Sano&Shigetaka Shimodaira, SCIENTIFIC REPORTS7:42145Feb. 2017
  • Significance of Wilms tumor 1 antigen as a canser vaccine for pancreatic cancer, Koido.S, Okamoto.M ,Kobayashi.M, Shimodaira.S, Sugiyama.H, Discovery Medicine130:41-49Aug. 2017
  • Clinical effect and immunological response in patients with advanced malignant glioma treated with WT1-pulsed dendritic cell-based immunotherapy: A report of two cases., Sakai K, Shimodaira S, Maejima S, Sano K, Higuchi Y, Koya T, Sugiyama H, Hongo K., Interdisciplinary Neurosurgery9:24-292017
  • Administration of platelet concentrates suspended in bicarbonated Ringer's solution in children who had platelet transfusion reactions, (Kobayashi J), Yanagisawa R, Ono T, Tatsuzawa Y, Tokutake Y, Kubota N, Hidaka E, Sakashita K, Kojima S, Shimodaira S, Nakamura T, VOX SANGUINIS113:128-135Feb. 2018
  • Comparison of administration of platelet concentrates suspended in M-sol or BRS-A for pediatric patients, (Shunsuke Kojima), Ryu Yanagisawa, Miyuki Tanaka, Yozo Nakazawa, Shigetaka Shimodaira, TRANSFUSION58:2952-2958Dec. 2018
  • Evaluation of Gelatin-Hybridized Chelate-Setting Calcium Phosphate Cements in Alveolar Bone Defects of Canine Mandible, Goichi Matsumoto, Yoshihiko Sugita, Katsutoshi Kubo, Waka Yoshida, Hatsuhiko Maeda, Mamoru Aizawa, Shigetaka Shimodaira, Yukihiko Kinoshita, Biomedical Journal of Scientific & Technical Research3:3420-3426Apr. 2018
  • Feasibility and Immune Response of WT1 Peptide Vaccination in Combination with OK-432 for Paediatric Solid Tumors, (Hirabayashi K), Yanagisawa R, Saito S, Higuchi Y, Koya T, Sano K, Koido S, Okamoto M, Sugiyama H, Nakazawa Y, Shimodaira S, ANTICANCER RESEARCH38:2227-2234Apr. 2018
  • Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma, (Tomoya Kanai), Zensho Ito, Yusuke Oji, Machi Suka, Sumiyuki Nishida, Kazuki Takakura, Mikio Kajihara, Masayuki Saruta, Shuichi Fujioka, Takeyuki Misawa, Tadashi Akiba, Hiroyuki Yanagisawa, Shigetaka Shimodaira, Masato Okamoto, Haruo Sugiyama, Shigeo Koido, Oncology Letters16:2682-2692Aug. 2018
  • WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study, (Yanagisawa R), Koizumi T, Koya T, Sano K, Koido S, Nagai K, Kobayashi M, Okamoto M, Sugiyama H, Shimodaira S, ANTICANCER RESEARCH38:2217-2225Apr. 2018
  • Dendritic Cells Pre-Pulsed With Wilms' Tumor 1 in Optimized Culture for Cancer Vaccination, Terutsugu Koya, Ippei Date, Haruhiko Kawaguchi, Asuka Watanabe, Takuya Sakamoto, Misa Togi, Tomohisa Kato Jr, Kenichi Yoshida, Shunsuke Kojima, Ryu Yanagisawa, Shigeo Koido, Haruo Sugiyama , Shigetaka Shimodaira, Pharmaceutics12: Mar. 2020
  • Complete measurable residual disease response after combination chemotherapy with AML-type and ALL-type regimens in pediatric B/myeloid acute bilineal leukemia, (Shoji Saito), Chiaki Taira, Kazuyuki Matsuda, Ryu Yanagisawa, Daisuke Morita, Tomonari Shigemura, Kentaro Yoshikawa, Miyuki Tanaka, Kazuo Sakashita, Saki Mukai, Shigetaka Shimodaira, Kenichi Koike, Yozo Nakazawa, Leukemia & Lymphoma61:967-970Apr. 2020
  • Investigation of factors associated with allergic transfusion reaction due to platelet transfusion and the efficacy of platelets resuspended in BRS‐A in adult patients, (Manjiro Yamanaka), Ryu Tanagisawa, Shunsuke Kojima, Hideyuki Nakazawa, Shigetaka Shimodaira, Transfusion59:3405-3412Dec. 2019
  • Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1, (Ito Z), Kan S, Bito T, Horiuchi S, Akasu T, Yoshida S, Kajihara M, Hokari A, Saruta M, Yoshida N, Kobayashi M, Ohkusa T, Shimodaira S, Okamoto M, Sugiyama H, Koido S, Oncology97:135-148Sep. 2019
  • In Vivo Administration of Recombinant Human Granulocyte Colony-Stimulating Factor Increases the Immune Effectiveness of Dendritic Cell-Based Cancer Vaccination, Shimodaira S, Yanagisawa R, Koya T, Hirabayashi K, Higuchi Y, Sakamoto T, Togi M, Kato T Jr, Kobayashi T, Koizumi T, Koido S, Sugiyama H, Vaccines (Basel)7:120Sep. 2019


Copyright (c) MEDIA FUSION Co.,Ltd. All rights reserved.